IN3BIO LTD has a total of 27 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Israel, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are UBI IP HOLDINGS, SYNTHON BIOPHARMACEUTICALS BV and CHEN LAN BO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 6 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Hungary | 1 | |
#12 | Serbia | 1 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change mitigation in goods production | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | D'Hondt Erik | 21 |
#2 | Charlton Keith Alan | 10 |
#3 | Molina Vila Miguel Angel | 3 |
#4 | Molina-Vila Miguel Angel | 3 |
#5 | Charlton Keith | 2 |
#6 | Verhamme Daniel T | 1 |
#7 | Erik D'Hondt | 1 |
#8 | Molina-Vila Miguel Ángel | 1 |
#9 | Molina-Vila Miguel | 1 |
#10 | Molina Vila Miguel Ángel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020260947A1 | Stabilized chimeric synthetic proteins and therapeutic uses thereof | |
AU2019319109A1 | Methods and compositions for inhibition of EGF/EGFR pathway in cobination with anaplastic lymphoma kinase inhibitors | |
US2019358320A1 | Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors | |
CA3070034A1 | Synthetic proteins and therapeutic uses thereof |